...
首页> 外文期刊>Biosciences Biotechnology Research Asia >Sequence and Structure Analysis of CRP of Lung and Breast Cancer Using Bioinformatics Tools and Techniques
【24h】

Sequence and Structure Analysis of CRP of Lung and Breast Cancer Using Bioinformatics Tools and Techniques

机译:使用生物信息学工具和技术对肺癌和乳腺癌CRP的序列与结构分析

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In the present study, bioinformatics approach has been adopted to explore the sequences and structures analysis of CRP of lung and breast cancer and compares with normal sequence from NCBI. The present study was aimed to investigate the possibility ofusing CRP as a marker for patients with lung and breast cancer. Also the effect of mutation on the physicochemical properties and structure of CRP. 40 blood and serum samples were examined from patients with lung and breast cancer (aged between 23and 45years old). Qualitative test was done to detect the presence of CRP in the patient’s serum. The qualitative test showed that 3(7.5%) patients give positive result and 37(92.5%) patients with lung and breast cancer give negative result to presence of CRP in the serum.In patient with lung cancer five missense mutations and four deletion mutations detected. While in the patient with lung cancer four missense mutations ,six deletion mutations and eight insertion mutation detected by BLAST. One point mutation appeared in all patients at same site and has same effect, this meaning there are relationship between this mutation and cancer disease. This mutation recorded in NCBI, DDBJ and ENA with the numbers LC276938 and LC276937. The present study determinedthe physico-chemical properties of CRP such as their hydrophilic nature; alpha-helical structure and 3D structure. The results of present study Show that CRP consider non-specific marker for patient with Lung and breast cancenAlso the mutations on CRP gene effected on the structure and physico-chemical properties of C-reactive protein.
机译:在本研究中,已采用生物信息学方法来探索肺癌和乳腺癌CRP的序列和结构分析,并与NCBI的正常序列进行比较。本研究旨在探讨CRP作为肺癌和乳腺癌患者的标志物的可能性。还突变对CRP的物理化学性质和结构的影响。从肺癌和乳腺癌患者中检查了40件血液和血清样品(老年人在45岁之间)。进行定性测试以检测患者血清中CRP的存在。定性测试表明,3例(7.5%)患者提供阳性结果,37例(92.5%)肺癌和乳腺癌患者患者在血清中的CRP存在下存在负面影响。肺癌患者五个畸形突变和四次缺失突变检测到患者。而在患有肺癌的患者中,六个畸形突变,六种缺失突变和爆炸检测的八个插入突变。在同一部位的所有患者中出现了一个点突变并且具有相同的效果,这意味着这种突变和癌症病之间存在关系。该突变记录在NCBI,DDBJ和ENA中,具有数字LC276938和LC276937。本研究确定了CRP的物理化学性质,如亲水性质; α-螺旋结构和3D结构。本研究结果表明,CRP考虑肺癌和乳腺癌患者的非特异性标志物对C-反应蛋白的结构和物理化学性质进行CRP基因的突变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号